Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Hewing

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Circulation|November 6, 2022
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 StudyHolger Reinecke, Christiane Engelbertz, Rupert Bauersachs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 11, 2014
Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in miceBernd Hewing, Saj Parathath, Tessa Barrett, et al.
Nature Communications|January 22, 2014
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammationRaphaël Duivenvoorden, Jun Tang, David P Cormode, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Circulation|November 6, 2022
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 StudyHolger Reinecke, Christiane Engelbertz, Rupert Bauersachs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 11, 2014
Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in miceBernd Hewing, Saj Parathath, Tessa Barrett, et al.
Nature Communications|January 22, 2014
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammationRaphaël Duivenvoorden, Jun Tang, David P Cormode, et al.
Pageof 4